Mr. Richard Corbridge:

The Deputy mentioned stakeholder engagement and buy-in from eHealth Ireland. We have phenomenal engagement from a clinical point of view out into our hospitals, community settings and GP user groups. Probably the biggest part of the role today is trying to make sure that engagement is there. We are trying to ensure that people understand the eHealth Ireland journey and the direction of travel. One of the ways we have done this is by trying to pick projects that we can deliver each year, as well as the end goal. Projects like epilepsy genomic sequencing, the bipolar project and those lighthouse projects were picked very much to invest time, effort, money and communications in order to engage different cohorts of people in how we can drive benefit to different patients. The success has been phenomenal, and we would in particular call out the epilepsy area. We believe Ireland is the first country in the world to start a genomic sequencing programme for epilepsy so that, by sequencing the genome of a child under the age of five, one can find out what is the right drug for that child. There is no need to try lots of different drugs and we will no longer have 90 children under the age of five dying. It is a huge programme of benefit and one that other countries can and will be able to learn from.